Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
GABA is a neurotransmitter that reduces brain activity, but it's also a supplement that could help with sleep.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback